Evidence mapPaperPMID 38446539Full record

Observational studyJMIR human factors2024

Leveraging Generative AI Tools to Support the Development of Digital Solutions in Health Care Research: Case Study.

Danissa V Rodriguez, Katharine Lawrence, Javier Gonzalez, Beatrix Brandfield-Harvey, Lynn Xu, Sumaiya Tasneem, Defne L Levine, Devin Mann

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in JMIR human factors, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04049500 (An Observational Study to Adapt a Digital Diabetes Prevention Program), which is not on this map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04049500 withdrawnnot on this map

An Observational Study to Adapt a Digital Diabetes Prevention Program (dDPP) and Incorporate it Into the Clinical Workflows.

TypeobservationalSponsorNYU Langone HealthRan2021 to 2026Enrolled0ConditionsPhysician-Patient Relations, Nurse-Patient RelationsArmsDigital Diabetes Prevention Program (dDPP)
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Danissa V RodriguezDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, United States.ORCID 0000-0003-4642-6798
Katharine LawrenceDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, United States.ORCID 0000-0001-5640-2138
Javier GonzalezMedical Center Information Technology, Department of Health Informatics, New York University Langone Health, New York, NY, United States.ORCID 0000-0002-7562-6070
Beatrix Brandfield-HarveyDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, United States.ORCID 0009-0002-0120-6353
Lynn XuDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, United States.ORCID 0009-0009-8586-9955
Sumaiya TasneemDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, United States.ORCID 0000-0001-5721-1819
Defne L LevineDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, United States.ORCID 0009-0000-5238-3144
Devin MannDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, United States.ORCID 0000-0002-2099-0852

Funding

New York Regional Center for Diabetes Translation ResearchP30DK111022 · ALBERT EINSTEIN COLLEGE OF MEDICINE · 2025 to 2025
$810k
NIDDK NIH HHS P30 DK111022NIDDK NIH HHS R18 DK118545
6 · The paper itself

Abstract

backgroundGenerative artificial intelligence has the potential to revolutionize health technology product development by improving coding quality, efficiency, documentation, quality assessment and review, and troubleshooting.

objectiveThis paper explores the application of a commercially available generative artificial intelligence tool (ChatGPT) to the development of a digital health behavior change intervention designed to support patient engagement in a commercial digital diabetes prevention program.

methodsWe examined the capacity, advantages, and limitations of ChatGPT to support digital product idea conceptualization, intervention content development, and the software engineering process, including software requirement generation, software design, and code production. In total, 11 evaluators, each with at least 10 years of experience in fields of study ranging from medicine and implementation science to computer science, participated in the output review process (ChatGPT vs human-generated output). All had familiarity or prior exposure to the original personalized automatic messaging system intervention. The evaluators rated the ChatGPT-produced outputs in terms of understandability, usability, novelty, relevance, completeness, and efficiency.

resultsMost metrics received positive scores. We identified that ChatGPT can (1) support developers to achieve high-quality products faster and (2) facilitate nontechnical communication and system understanding between technical and nontechnical team members around the development goal of rapid and easy-to-build computational solutions for medical technologies.

conclusionsChatGPT can serve as a usable facilitator for researchers engaging in the software development life cycle, from product conceptualization to feature identification and user story development to code generation.

trial registrationClinicalTrials.gov NCT04049500; https://clinicaltrials.gov/ct2/show/NCT04049500.

Indexed as

Artificial IntelligenceHealth Services ResearchBenchmarkingBiomedical TechnologyHumansSoftwareappapplicationapplicationsappsartificial intelligencebehavior changebehaviour changeChatGPTdeveloperdevelopersdiabetesdiabetes preventiondiabeticdigital healthdigital prescriptionengagementGenAIgenerativelanguage modellanguage modelsLLMLLMsmHealthmobile healthnatural language processingNLPsoftwaresoftware engineering

Identifiers

PMID38446539
PMCPMC10955400

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.